RGT 10.3% 35.0¢ argent biopharma limited

where are you cavalabs?, page-95

  1. 14,097 Posts.
    lightbulb Created with Sketch. 2412
    I am curious about what is holding up the VC deal. Is it that VC are unable to produce products from what raw materials MXC supplies or is it a financial reason - cash flow or even that they misjudged demand for the products they will produce?
    MXC has clearly given them the opportunity to get their act together so they must have assumed VC could uphold their part of the bargain given more time.
    I note from what you said from MXC's comments to you that they are starting to take a harder line with VC - essentially giving them until the end of the year to come good or face the legal option of redress. Do you think that could be an indication that MXC is losing patience or faith in VC?

 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.